PT - JOURNAL ARTICLE AU - Kevin B. Wilkins AU - Jordan E. Parker AU - Helen M. Bronte-Stewart TI - Atrophy of the Nucleus Basalis of Meynert predicts the progression of gait variability in Parkinson’s disease AID - 10.1101/2020.05.12.20099523 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.12.20099523 4099 - http://medrxiv.org/content/early/2020/06/28/2020.05.12.20099523.short 4100 - http://medrxiv.org/content/early/2020/06/28/2020.05.12.20099523.full AB - Parkinson’s disease (PD) is a systemic brain disorder where the cortical cholinergic network begins to degenerate early in the disease process. Readily accessible, quantitative, and specific behavioral markers of the cortical cholinergic network are lacking. Although degeneration of the dopaminergic network may be responsible for deficits in cardinal motor signs, the control of gait is a complex process and control of higher-order aspects of gait, such as gait variability, may be influenced by cognitive processes attributed to cholinergic networks. We investigated whether swing time variability, a metric of gait variability that is independent from gait speed, was a quantitative behavioral marker of cortical cholinergic network integrity in PD. Twenty-two individuals with PD and twenty-nine age-matched controls performed a validated stepping-in-place (SIP) task to assess swing time variability off all therapy. The PD cohort also underwent structural MRI scans to measure gray matter volume of the Nucleus Basalis of Meynert (NBM), the key node in the cortical cholinergic network. Swing time variability was also measured ON subthalamic nucleus (STN) deep brain stimulation (DBS) in PD individuals. A subset of eleven individuals with PD completed the SIP task again off all therapy after three years of continuous DBS. Clinical motor assessments were performed for each condition. Swing time variability was significantly greater (i.e., worse) in PD compared to controls and greater swing time variability was related to greater atrophy of the NBM. STN DBS significantly improved cardinal motor signs but did not improve swing time variability. Swing time variability worsened in PD, off therapy, after three years of continuous STN DBS, and NBM atrophy predicted the degree of increase. In contrast, cardinal motor signs did not progress. These results demonstrate that swing time variability is a reliable marker of cortical cholinergic health, and support a framework in which higher-order aspects of gait control in PD are reliant on the cortical cholinergic system, in contrast to other motor aspects of PD that rely on the dopaminergic network.Competing Interest StatementDr. Bronte-Stewart serves on a clinical advisory board for Medtronic, Inc.Funding StatementThis work was supported in part by the following: NINDS UH3NS107709, NINDS R21 NS096398-02, Michael J. Fox Foundation (9605), Parkinson's Foundation Postdoctoral Fellowship PF-FBS-2024, Robert and Ruth Halperin Foundation, John A. Blume Foundation, Smart Family Foundation, John E Cahill Family Foundation, and Medtronic Inc. who provided the devices used in this study but no additional financial support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Stanford University Institutional Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available on request when possible.AChAcetylcholineCVCoefficient of VariationDBSDeep brain stimulationFWEFamily-wise errorIPInitial ProgrammingNBMNucleus Basalis of MeynertPDParkinson’s DiseasePPNPedunculopontine nucleusSIPStepping-In-PlaceSTNSubthalamic NucleusUPDRSUnified Parkinson’s Disease Rating Scale